Case Control Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3832-3838
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3832
Table 1 Comparison of serum UL16-binding protein 2 and DR-70 levels among the colorectal cancer, benign, and control groups, mean ± SD
Group
ULBP2 (ng/L)
DR-70 (μg/mL)
CRC (n = 60)84.28 ± 13.52a1.28 ± 0.41a
Benign (n = 50)68.04 ± 8.890.48 ± 0.15
Control (n = 50)66.93 ± 9.150.46 ± 0.14
F value44.392161.273
P value< 0.001< 0.001